Abstract:OBJECTIVE:Although repeat microvascular decompression (MVD) for hemifacial spasm (HFS) in patients with failed prior MVD is potentially curative, little is known about the long-term results of repeat MVD. We aimed to evaluate the long-term outcomes and complications after repeat MVD for HFS.METHODS:We performed repeat MVD on 78 consecutive patients who had undergone a prior MVD >1 year previously. Follow-up data were available for 58 patients, with a median follow-up period of 8.6 years (range, 6.9-10.2 years). The patients were assessed for intraoperative findings, relief results, and complications at discharge and at follow-up, as well as the associations between the preoperative characteristics and outcomes.RESULTS:At discharge, of 78 patients with repeat MVD, 72 (92.3%) achieved complete spasm resolution and 1 (2.6%) had significantly improved spasm resolution. Of all patients, 9% (7 of 78) presented short-term complications, including partial hearing loss, hemifacial paresis, and cerebrospinal fluid leak. At follow-up, 45 of 58 (77.6%) patients had complete relief and 10 of 58 (17.2%) had improved relief. Permanent complications occurred in 14 patients (24.1%), with partial hearing loss and mild hemifacial paresis being the most common. Despite the complications, 51 of 58 patients (91.4%) reported an excellent life quality. No significant correlation was found between preoperative characteristics, such as age, interval to prior MVD, or interval to recurrence, and outcomes including short-term or long-term relief results and complications.CONCLUSIONS:Repeat MVD provides lasting relief for most patients with persistent or recurrent HFS, albeit with a relatively high complication rate.

Hemifacial Spasm: Comparison of Results Between Patients Older and Younger Than 70 Years Operated on with Microvascular Decompression.

Clinical Characteristics and Efficacy of Microvascular Decompression for Young Onset Hemifacial Spasm Patients

Clinical analysis of microvascular decompression in patients with hemifacial spasm: a retrospective study

Long-term outcome of microvascular decompression for hemifacial spasm

Microvascular Decompression Surgery for Hemifacial Spasm

Microvascular Decompression for Hemifacial Spasm Associated with Distinct Offending Vessels: A Retrospective Clinical Study

Safety and efficacy of endoscope-assisted versus microscopic microvascular decompression surgery for hemifacial spasm: a prospective cohort study

Clinical analysis of hemifacial spasm patients with delay symptom relief after microvascular decompression of distinct offending vessels

Microvascular decompression in patients with hemifacial spasm

Endoscope-assisted Microvascular Decompression of the Hemifacial Spasm

Analysis of Postoperative Complications of Microvasular Decompression for Hemifacial Spasm

Results from 228 patients with Hemifacial Spasm Undergoing Microvascular Decompression without Intraoperative Neuroelectrophysiology Monitoring

Long-term Outcomes of Treating Hemifacial Spasm with Microvascular Decompression

Microvascular Decompression to Treat Hemifacial Spasm: a Review of 4260 Operations Performed During the Past 20 Years

Long-Term Outcome of Repeat Microvascular Decompression for Hemifacial Spasm.

How to Improve the Effect of Microvascular Decompression for Hemifacial Spasm: A Retrospective Study of 32 Cases with Unsuccessful First Time MVD

[An analysis of clinical efficacy of microvascular decompression for 21 inpatients suffering from primary hemifacial spasm]

Long-term Outcomes of Microvascular Decompression in the Treatment of Hemifacial Spasm Based on Different Offending Vessels

Ca(2+)-antagonistic action of bevantolol on hypothalamic neurons in vitro: its comparison with those of other beta-adrenoceptor antagonists, a local anesthetic and a Ca(2+)-antagonist.

Outcome of microvascular decompression for hemifacial spasm associated with the vertebral artery

[Causes of Ineffectiveness of Microvascular Decompression for Hemifacial Spasm].